Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,244 | 370 | 99.9% |
| Education | $11.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,344 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,256 | 27 | $0 (2024) |
| ABBVIE INC. | $1,123 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,031 | 61 | $0 (2024) |
| PFIZER INC. | $576.01 | 31 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $309.32 | 18 | $0 (2024) |
| Lilly USA, LLC | $245.30 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $243.29 | 10 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $215.19 | 12 | $0 (2022) |
| GlaxoSmithKline, LLC. | $198.63 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,234 | 108 | AstraZeneca Pharmaceuticals LP ($728.33) |
| 2023 | $1,909 | 68 | Amgen Inc. ($442.27) |
| 2022 | $947.10 | 50 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($203.56) |
| 2021 | $1,040 | 53 | AbbVie Inc. ($255.15) |
| 2020 | $633.01 | 31 | PFIZER INC. ($146.91) |
| 2019 | $545.69 | 26 | Neuronetics, Inc. ($147.57) |
| 2018 | $543.70 | 21 | AstraZeneca Pharmaceuticals LP ($312.62) |
| 2017 | $404.68 | 14 | Novartis Pharmaceuticals Corporation ($157.89) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Analgesic | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Analgesic | ||||||
| 12/21/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Respiratory | ||||||
| 11/28/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $0.91 | General |
| Category: Analgesic | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Analgesic | ||||||
| 11/25/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Neurology | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $109.20 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 808 | 2,463 | $260,434 | $132,842 |
| 2022 | 14 | 709 | 2,315 | $231,304 | $125,596 |
| 2021 | 16 | 552 | 1,438 | $177,465 | $93,269 |
| 2020 | 15 | 449 | 1,072 | $135,595 | $60,130 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 270 | $66,800 | $28,938 | 43.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 67 | 449 | $44,750 | $25,540 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 340 | $43,730 | $24,418 | 55.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 65 | 382 | $28,650 | $16,486 | 57.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 21 | 204 | $10,838 | $7,816 | 72.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 142 | $14,200 | $6,459 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 135 | $10,230 | $5,722 | 55.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 30 | $9,000 | $4,487 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $3,600 | $3,528 | 98.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 20 | 95 | $10,506 | $3,389 | 32.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 20 | 20 | $2,880 | $1,270 | 44.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 129 | $2,580 | $1,084 | 42.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 19 | $1,520 | $696.78 | 45.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 31 | 31 | $2,150 | $663.78 | 30.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 51 | $3,060 | $614.29 | 20.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 46 | $3,220 | $544.80 | 16.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 17 | 18 | $900.00 | $530.28 | 58.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $700.00 | $301.28 | 43.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 15 | 16 | $400.00 | $300.96 | 75.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 48 | $720.00 | $52.37 | 7.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 84 | 456 | $45,497 | $27,357 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 339 | $42,330 | $25,438 | 60.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 222 | $53,650 | $23,729 | 44.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 67 | 305 | $22,875 | $13,907 | 60.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 32 | 234 | $23,400 | $11,623 | 49.7% |
About Dr. Arthur Pinkhasov, MD
Dr. Arthur Pinkhasov, MD is a Internal Medicine healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1588946396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Pinkhasov, MD has received a total of $9,256 in payments from pharmaceutical and medical device companies, with $3,234 received in 2024. These payments were reported across 371 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($9,244).
As a Medicare-enrolled provider, Pinkhasov has provided services to 2,518 Medicare beneficiaries, totaling 7,288 services with total Medicare billing of $411,837. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Forest Hills, NY
- Active Since 09/16/2011
- Last Updated 11/12/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588946396
Products in Payments
- XIFAXAN (Drug) $886.62
- Otezla (Drug) $701.30
- AIRSUPRA (Drug) $554.10
- VRAYLAR (Drug) $455.76
- Repatha (Biological) $423.31
- BEVESPI AEROSPHERE (Drug) $370.50
- NURTEC ODT (Drug) $347.78
- UBRELVY (Drug) $307.03
- ZTLido (Drug) $266.49
- Aimovig (Biological) $219.12
- NASCOBAL (Drug) $215.19
- ENTRESTO (Drug) $201.30
- PURIFIED CORTROPHIN GEL (Drug) $190.90
- BREZTRI (Drug) $184.95
- COLOGUARD (Device) $179.76
- MOUNJARO (Drug) $171.29
- Kerendia (Drug) $168.96
- PENNSAID (Drug) $164.45
- Linzess (Drug) $156.02
- CeQur Simplicity (Device) $147.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Forest Hills
Dr. Oluwafemi Akinbode, Md, MD
Internal Medicine — Payments: $277,600
Albert Shalomov, Md, MD
Internal Medicine — Payments: $110,334
Dr. Simon Lipetz, M.d, M.D
Internal Medicine — Payments: $17,534
Dr. Gavriel Fuzaylov, Md, MD
Internal Medicine — Payments: $17,253
David Tavdy, Md, MD
Internal Medicine — Payments: $16,147
Vladimir Gabay, M.d, M.D
Internal Medicine — Payments: $7,051